title: Chemical space sampling by different scoring functions and crystal structures.
abstract: Virtual screening has become a popular tool to identify novel leads in the early phases of drug discovery. A variety of docking and scoring methods used in virtual screening have been the subject of active research in an effort to gauge limitations and articulate best practices. However, how to best utilize different scoring functions and various crystal structures, when available, is not yet well understood. In this work we use multiple crystal structures of PI3 K-gamma in both prospective and retrospective virtual screening experiments. Both Glide SP scoring and Prime MM-GBSA rescoring are utilized in the prospective and retrospective virtual screens, and consensus scoring is investigated in the retrospective virtual screening experiments. The results show that each of the different crystal structures that was used, samples a different chemical space, i.e. different chemotypes are prioritized by each structure. In addition, the different (re)scoring functions prioritize different chemotypes as well. Somewhat surprisingly, the Prime MM-GBSA scoring function generally gives lower enrichments than Glide SP. Finally we investigate the impact of different ligand preparation protocols on virtual screening enrichment factors. In summary, different crystal structures and different scoring functions are complementary to each other and allow for a wider variety of chemotypes to be considered for experimental follow-up.
authors.affiliation: Structural Biology and Computational Chemistry, Wyeth Research, 401 N Middletown Road, Pearl River, NY, USA. reprints@prodigy.net
authors.forename: Natasja
authors.initials: N
authors.lastname: Brooijmans
authors.forename: Christine
authors.initials: C
authors.lastname: Humblet
mesh_terms: D000465:Algorithms; D020134:Catalytic Domain; D058544:Class Ib Phosphatidylinositol 3-Kinase; D003198:Computer Simulation; D018360:Crystallography, X-Ray; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000737:chemistry; D008024:Ligands; D008958:Models, Molecular; D019869:Phosphatidylinositol 3-Kinases / Q000737:chemistry; D000081082:Phosphoinositide-3 Kinase Inhibitors; D012984:Software; D014584:User-Computer Interface
chemical_list: D058544:Class Ib Phosphatidylinositol 3-Kinase; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D008024:Ligands; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors
references.citation: Bioorg Med Chem. 2006 Jul 15;14(14):4792-802
references.pmid: 16574416
references.citation: Proteins. 2006 Jan 1;62(1):202-8
references.pmid: 16287127
references.citation: J Med Chem. 1999 Dec 16;42(25):5100-9
references.pmid: 10602695
references.citation: J Med Chem. 2004 Mar 25;47(7):1739-49
references.pmid: 15027865
references.citation: Proteins. 2003 Sep 1;52(4):609-23
references.pmid: 12910460
references.citation: Curr Opin Chem Biol. 2004 Aug;8(4):365-70
references.pmid: 15288245
references.citation: Proteins. 2004 Jun 1;55(4):814-23
references.pmid: 15146480
references.citation: J Chem Inf Model. 2008 Mar;48(3):659-68
references.pmid: 18324799
references.citation: J Med Chem. 2008 Jun 26;51(12):3499-506
references.pmid: 18517186
references.citation: J Comput Aided Mol Des. 2009 Jun;23(6):355-74
references.pmid: 19340588
references.citation: J Med Chem. 2004 Jan 1;47(1):45-55
references.pmid: 14695819
references.citation: J Chem Inf Model. 2009 Jun;49(6):1455-74
references.pmid: 19476350
references.citation: J Comput Aided Mol Des. 2009 Aug;23(8):527-39
references.pmid: 19495993
references.citation: Acta Pharmacol Sin. 2006 Sep;27(9):1259-71
references.pmid: 16923349
references.citation: J Mol Biol. 2004 Apr 9;337(5):1161-82
references.pmid: 15046985
references.citation: J Med Chem. 2001 Mar 29;44(7):1035-42
references.pmid: 11297450
references.citation: Proteins. 1998 Nov 1;33(2):227-39
references.pmid: 9779790
references.citation: Bioorg Med Chem Lett. 2007 Jul 15;17(14):3880-5
references.pmid: 17570665
references.citation: J Mol Biol. 1997 Apr 4;267(3):727-48
references.pmid: 9126849
references.citation: J Med Chem. 2006 Oct 19;49(21):6177-96
references.pmid: 17034125
references.citation: J Comput Aided Mol Des. 2008 Mar-Apr;22(3-4):133-9
references.pmid: 18338228
references.citation: J Med Chem. 2006 Apr 20;49(8):2363-6
references.pmid: 16610779
references.citation: Bioorg Med Chem Lett. 2008 Oct 15;18(20):5372-6
references.pmid: 18835158
references.citation: J Med Chem. 2009 Feb 26;52(4):943-51
references.pmid: 19199650
references.citation: J Mol Biol. 2001 Apr 27;308(2):377-95
references.pmid: 11327774
references.citation: J Chem Inf Model. 2009 Aug;49(8):1871-8
references.pmid: 19645429
references.citation: Nat Rev Drug Discov. 2006 Nov;5(11):903-18
references.pmid: 17080027
references.citation: J Comput Aided Mol Des. 2008 Mar-Apr;22(3-4):257-65
references.pmid: 18273559
references.citation: J Med Chem. 2005 Jan 13;48(1):200-12
references.pmid: 15634014
references.citation: J Chem Inf Comput Sci. 2004 May-Jun;44(3):1123-9
references.pmid: 15154781
references.citation: J Med Chem. 2004 Oct 7;47(21):5076-84
references.pmid: 15456251
references.citation: Proteins. 2002 Jan 1;46(1):34-40
references.pmid: 11746701
references.citation: J Mol Biol. 2004 Mar 12;337(1):209-25
references.pmid: 15001363
references.citation: Mol Cancer Ther. 2008 Aug;7(8):2386-93
references.pmid: 18723485
references.citation: Curr Med Chem. 2004 Mar;11(6):693-707
references.pmid: 15032724
references.citation: J Chem Inf Comput Sci. 2004 May-Jun;44(3):793-806
references.pmid: 15154744
references.citation: Proteins. 2004 Aug 1;56(2):235-49
references.pmid: 15211508
references.citation: J Mol Biol. 1997 Feb 21;266(2):424-40
references.pmid: 9047373
references.citation: J Med Chem. 2007 Feb 22;50(4):726-41
references.pmid: 17300160
references.citation: J Comput Aided Mol Des. 2002 Dec;16(12):855-69
references.pmid: 12825619
references.citation: J Med Chem. 2005 Jun 30;48(13):4432-43
references.pmid: 15974595
references.citation: J Med Chem. 2008 Apr 24;51(8):2502-11
references.pmid: 18333608
references.citation: J Mol Biol. 1994 Jan 7;235(1):345-56
references.pmid: 8289255
references.citation: Proteins. 1999 Nov 1;37(2):228-41
references.pmid: 10584068
references.citation: J Med Chem. 2008 Mar 13;51(5):1179-88
references.pmid: 18271520
references.citation: J Chem Inf Model. 2008 May;48(5):1081-91
references.pmid: 18465849
references.citation: Drug Discov Today. 2006 May;11(9-10):421-8
references.pmid: 16635804
references.citation: Bioorg Med Chem. 2009 Apr 1;17(7):2759-66
references.pmid: 19285872
references.citation: J Comput Chem. 2007 Jun;28(8):1364-72
references.pmid: 17342720
references.citation: Bioorg Med Chem Lett. 2003 Nov 3;13(21):3693-9
references.pmid: 14552760
references.citation: J Med Chem. 2002 Mar 28;45(7):1412-9
references.pmid: 11906282
references.citation: J Mol Biol. 1985 Aug 5;184(3):503-16
references.pmid: 4046024
references.citation: J Med Chem. 2007 Aug 23;50(17):3980-3
references.pmid: 17676727
references.citation: J Med Chem. 2008 Oct 9;51(19):6121-6127
references.pmid: 18783202
references.citation: Science. 1991 Apr 5;252(5002):106-9
references.pmid: 2011744
references.citation: Annu Rev Phys Chem. 2000;51:129-52
references.pmid: 11031278
references.citation: J Chem Inf Model. 2008 May;48(5):958-70
references.pmid: 18422307
references.citation: J Med Chem. 2008 Mar 27;51(6):1972-5
references.pmid: 18290603
references.citation: J Med Chem. 2005 Jul 14;48(14):4586-95
references.pmid: 15999996
references.citation: J Med Chem. 2005 Feb 24;48(4):962-76
references.pmid: 15715466
references.citation: Bioorg Med Chem Lett. 2008 Jun 1;18(11):3152-7
references.pmid: 18486472
references.citation: J Comput Chem. 2005 Jan 15;26(1):11-22
references.pmid: 15526325
references.citation: Annu Rev Biophys Biomol Struct. 2003;32:335-73
references.pmid: 12574069
references.citation: J Comput Aided Mol Des. 1999 Nov;13(6):547-62
references.pmid: 10584214
references.citation: J Med Chem. 2005 Jun 16;48(12):4040-8
references.pmid: 15943477
references.citation: J Med Chem. 2006 Oct 5;49(20):5912-31
references.pmid: 17004707
references.citation: J Med Chem. 2005 May 5;48(9):3221-30
references.pmid: 15857128
references.citation: J Chem Inf Model. 2007 Nov-Dec;47(6):2293-302
references.pmid: 17956084
references.citation: BMC Microbiol. 2006 Nov 10;6:96
references.pmid: 17094812
references.citation: Bioorg Med Chem Lett. 2008 Oct 15;18(20):5672-5
references.pmid: 18799313
references.citation: Bioorg Med Chem Lett. 2006 Apr 1;16(7):1969-74
references.pmid: 16413185
references.citation: Protein Sci. 2005 Apr;14(4):1104-14
references.pmid: 15772311
references.citation: Drug Discov Today. 2006 Jul;11(13-14):580-94
references.pmid: 16793526
references.citation: Mol Cancer Ther. 2006 Jul;5(7):1764-73
references.pmid: 16891462
references.citation: J Mol Biol. 1982 Jun 5;157(4):671-9
references.pmid: 6288964
references.citation: J Chem Inf Model. 2008 Jun;48(6):1269-78
references.pmid: 18533645
references.citation: J Chem Inf Model. 2005 Jul-Aug;45(4):1061-74
references.pmid: 16045302